Action AJINY AJINOMOTO CO., INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Ajinomoto Co., Inc. OTC Markets

Actions

AJINY

US0097071007

Marché Fermé - OTC Markets
Autres places de cotation
 21:59:59 28/06/2024 		Varia. 5j. Varia. 1 janv.
35,24 USD -2,38 % Graphique intraday de Ajinomoto Co., Inc. +1,21 % -8,15 %
09/05 Transcript : Ajinomoto Co., Inc., 2024 Earnings Call, May 09, 2024
09/05 Ajinomoto Co., Inc. (TSE:2802) annonce un rachat d'actions portant sur 12 500 000 actions, soit 2,44 %, pour un montant de 50 000 millions de yens. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Ajinomoto Co., Inc. announces an Equity Buyback for 12,500,000 shares, representing 2.44% for ¥50,000 million.
Ajinomoto Co., Inc. authorizes a Buyback Plan.
Ajinomoto : Enhancing Corporate Value through ASV Management
Ajinomoto : Sustainability Initiatives Aimed at Enhancement of Corporate Value
TechMagic, Inc. announced that it has received funding from a group of investors
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors
Ajinomoto Foods Restates Commitment to Quality Products
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research
Ribomic Enters Into Drug Research Collaboration with Ajinomoto
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
New acquisition to support global gene therapy manufacturing
Forge Biologics - Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Ajinomoto Co., Inc. übernimmt Forge Biologics für 620 Millionen Dollar1
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2802
  4. Action AJINY
  5. Actualités Ajinomoto Co., Inc.
  6. Autres langues